Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $2.4 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and clinical expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 70 Versant companies have achieved successful acquisitions or IPOs. For more information, please visit www.versantventures.com.
View Top Employees from Versant VenturesWebsite | http://www.versantventures.com |
Revenue | $8 million |
Employees | 62 (57 on RocketReach) |
Founded | 1999 |
Address | One Sansome Street Suite 3630, San Francisco, California 94104, US |
Phone | (415) 801-8100 |
Fax | (415) 801-8101 |
Technologies |
JavaScript,
HTML,
Microsoft Outlook
+34 more
(view full list)
|
Industry | Venture Capital and Private Equity Principals, Finance General, Financial Services, Biopharmaceuticals, Finance, Health Care, Medical Devices, Venture Capital, Life Science opportunities, Lending and Investments |
Web Rank | 4 Million |
Keywords | Versant Ventures, Monte Rosa Therapeutics, Charles Warden, Versant Ventures Team, Steve Edelson |
Competitors | ATP (Apple Tree Partners), Alta Partners, Collinson Howe Venture Partners, Domain Associates, Santé Ventures |
SIC | SIC Code 67 Companies, SIC Code 679 Companies |
NAICS | NAICS Code 523 Companies, NAICS Code 52 Companies, NAICS Code 5239 Companies |
Looking for a particular Versant Ventures employee's phone or email?
The Versant Ventures annual revenue was $8 million in 2024.
Max Eisenberg is the COO of Versant Ventures.
57 people are employed at Versant Ventures.
Versant Ventures is based in San Francisco, California.
The NAICS codes for Versant Ventures are [523, 52, 5239].
The SIC codes for Versant Ventures are [67, 679].